A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech n Beijing September 24, 2020. — Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, May 26 — Concern that the approval of China’s Sinovac Covid-19 vaccine could lead to shortages has led domestic pharmaceutical corporation Pharmaniaga Berhad to announce it will import 10 million more doses.
Its managing director Datuk Zulkarnain Md Eusope said the company has taken into account the unpredictability of vaccine supplies, given current geopolitics and supply issues around the world.
“There is the possibility of a vaccine supply shortage in Malaysia if this happens. The World Health Organisation (WHO) is expected to approve Sinovac’s vaccine very soon,” he said during a press conference.
MORE TO COME